Cargando…

Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review

Accumulating evidence regarding clinical, neurobiological, genetic, and environmental factors suggests a bidirectional link between obesity and depressive disorders. Although a few studies have investigated the link between obesity/excess body weight and the response to antidepressants in depressive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Young Sup, Seo, Hye-Jin, McIntyre, Roger S., Bahk, Won-Myong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730324/ https://www.ncbi.nlm.nih.gov/pubmed/26771598 http://dx.doi.org/10.3390/ijms17010080

Ejemplares similares

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
por: Woo, Young Sup, et al.
Publicado: (2016)

Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2020)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

PS150. Comparative efficacy of various augmentation strategies for treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
por: McIntyre, Roger S., et al.
Publicado: (2015)

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
por: Seo, Jeong Seok, et al.
Publicado: (2018)

Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors
por: Shim, In Hee, et al.
Publicado: (2017)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2017)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
por: Choi, Won-Seok, et al.
Publicado: (2022)

Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study
por: Chang, Seyeon, et al.
Publicado: (2021)

Ginkgo biloba induced mood dysregulation: a case report
por: Rho, Seung Sun, et al.
Publicado: (2018)

Naltrexone-associated Visual Hallucinations: A Case Report
por: Lee, Dae Bo, et al.
Publicado: (2019)

Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
por: Song, Hoo Rim, et al.
Publicado: (2015)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2018)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2021)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre, Roger S
Publicado: (2017)

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
por: Jang, Seung-Ho, et al.
Publicado: (2023)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2020)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2014)

The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis
por: Lee, Kyung Ho, et al.
Publicado: (2020)

Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
por: Woo, Young Sup, et al.
Publicado: (2017)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

The Brain–Gut–Microbiome Axis in Psychiatry
por: Jang, Seung-Ho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4t89lvqsk7k44icen4bdvuhog7